Topical immunotherapy with diphenylcyclopropenone-induced vitiligo

Kutlubay Z., Engin B., Songur A., Serdaroglu S., Tuzun Y.

JOURNAL OF COSMETIC AND LASER THERAPY, vol.18, no.4, pp.245-246, 2016 (SCI-Expanded) identifier identifier identifier


Topical immunotherapy made by diphenylcyclopropenone (DPCP) is an alternative treatment that can be used safely and efficaciously in recalcitrant alopecia areata patients. DPCP-induced vitiligo is a rare, but documented, unwanted side effect. The real mechanism of DPCP-induced vitiligo is not well known.